Email address
[email protected]Contact number
+43 1 522 5700Share profile
Up and Coming
Provided by Markus Arzt
Fund Formation, Capital Markets , Venture Capital & Start Ups and Corporate Law & Transactions
Start-up Guide Recht Sicher Steuern, dbv Verlag | 2020
EU-Verschmelzungsgesetz, Verlag Österreich | 2016
Investmentfondgesetz Kommentar, Linde Verlag | 2016
In recent years, Markus Arzt has spearheaded various large international transactions and is a respected venture capital and private equity expert.
University of Vienna, Faculty of Law (Mag. iur. 2012)
Advising BOA Group on the sale to Silverfleet
Advising numerous renowned VC funds and business angels on investments in targeted companies
Advised Sportradar AG on the investment of CPPIB and TCV
Co-founder of the BT Nährboden program, an initiative of Brandl Talos, which - very selectively - supports promising start-ups
Advising the majority shareholders (including Farallon, Global Health Investment Fund, Adjuvent Capital, Wellington Partners, Hadean Ventures and Ventech) on the sale of the Austrian biotechnology company Themis to Merck Sharp Dohme
Advising "Ring" International Holding AG on the acquisition of Helios and the sale of its coating division to Kansai
Provided by Chambers
Markus Arzt is often involved in M&A transactions and strategic investments, as well as fund structuring, frequently advising clients from the private equity and venture capital sectors.
Provided by Chambers
"Markus is a real rising star - competent, low ego, and solutions-oriented."
"He is among the best young corporate lawyers, with a great future."
"Markus is very pragmatic on a lot of things and helpful on complex deals."
"Markus is a real rising star - competent, low ego, and solutions-oriented."
"He is among the best young corporate lawyers, with a great future."
"Markus is very pragmatic on a lot of things and helpful on complex deals."
